Argenx Se ARGX
NASDAQ ARGX
$1,033.15 -20.31 (-1.93%)
At close: Sep 4, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Operating Income (2016 - 2026)

Argenx Se's (ARGX) quarterly Operating Income came in at $493.0 million in Q2 2026, up 145.2% on a YoY basis from $201.1 million in Q2 2025, and up 25.13% quarter-over-quarter from $394.0 million in Q1 2026.

Analysis

Argenx Se (ARGX) Operating Income (2016 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Operating Income for 11 consecutive years, with $493.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Income rose 145.2% year-over-year to $493.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.6 billion (up 250.06% YoY), and the FY2025 full-year result was $1.1 billion, up 4966.57% from the prior year.
  • Operating Income improved to $493.0 million in Q2 2026 per ARGX's latest filing, from $394.0 million in the prior quarter.
  • Across five years, Operating Income topped out at $493.0 million in Q2 2026 and bottomed at -$222.7 million in Q1 2022.
  • Historically, Operating Income has averaged $57.4 million across 5 years, with a median of -$15.6 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Operating Income slumped 1713176.92% in 2022, then surged 2340.22% in 2025.
  • Over 5 years, Operating Income stood at -$114.4 million in 2022, then dropped by 21.14% to -$138.6 million in 2023, then soared by 174.33% to $103.0 million in 2024, then jumped by 256.76% to $367.6 million in 2025, then surged by 34.11% to $493.0 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered $493.0 million, $394.0 million, and $367.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 1.29 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 493.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -815.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 231.44 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -644.50 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -1.55 Mn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn -1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 493.00 Mn
Mar 31, 2026 394.00 Mn
Dec 31, 2025 367.61 Mn
Sep 30, 2025 346.19 Mn
Jun 30, 2025 201.06 Mn
Mar 31, 2025 139.00 Mn
Dec 31, 2024 103.04 Mn
Sep 30, 2024 14.19 Mn
Jun 30, 2024 -45.46 Mn
Mar 31, 2024 -93.42 Mn
Dec 31, 2023 -138.62 Mn
Sep 30, 2023 -80.59 Mn
Jun 30, 2023 -102.09 Mn
Mar 31, 2023 -103.74 Mn
Dec 31, 2022 -114.43 Mn
Sep 30, 2022 -208.64 Mn
Jun 30, 2022 85.18 Mn
Mar 31, 2022 -222.73 Mn
Dec 31, 2021 -230.91 Mn
Sep 30, 2021 7.11 Mn